Get the (MYL) Report Here
Trade with Jim Cramer 14 Days FREE
Secular trends appear likely to favor Mylan and Teva Pharmaceuticals.
Break in! Morgan Stanley (MS) is defending Mylan (MYL) now.
These two pharmaceuticals are standouts as the sector outperforms today.
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login